We are live on ! Find out more
ARTL icon

Artelo Biosciences
ARTL

1 hedge funds and large institutions have $189K invested in Artelo Biosciences in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
+$196K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
1
CVI Holdings
Delaware
$189K +$196K +152 New

ARTL Hedge Fund Activity: Q2 2019 in Review

1 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences (ARTL) for Q2 2019, worth a combined $189K.

Buyers outnumbered sellers: 1 fund opened new ARTL positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was CVI Holdings, opening a new position worth an estimated $196K.

  • 1 institutional investor held Artelo Biosciences (ARTL) as of Q2 2019, up from 0 in Q1 2019.
  • Funds reported $189K of Artelo Biosciences stock for Q2 2019.
  • 1 fund opened new Artelo Biosciences positions in Q2 2019 and 0 closed out, a net change of +1 holder.
  • The largest Artelo Biosciences buyer in Q2 2019 was CVI Holdings, an estimated $196K added.

Based on aggregated 13F filings for Q2 2019.